Competition & Peer Data API & CSV Delivery

Inovalon Holdings Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Inovalon Holdings Inc (INOV) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q3 2021
Competitors Tracked
1
Publicly traded peers
Peer Group Market Share
68.95 %
vs 69.59 % a year ago
Revenue Growth Y/Y
19.12 %
Peers: 22.81 %
Net Margin
5.94 %
Peers: -19.76 %

Key Findings: Inovalon Holdings Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 750M vs 338M combined for tracked competitors (68.9% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+2.6% annualized vs trailing 12 months), vs accelerating (+2.4%) for its tracked peer group.
  • Growth: Inovalon Holdings Inc generated 19.1% revenue growth year over year in Q3 2021, vs 22.8% for its tracked competitors combined.
  • Profitability: Its 5.9% net margin compares with -19.8% for the peer group.
  • Peer revenue share: Inovalon Holdings Inc accounted for 69.0% of combined revenue among its tracked peer group, down from 69.6% a year earlier.
  • Peer differentiation: Revenue per employee of $0.25M compares with $0.42M for the peer group (0.6x).

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

INOV Sales vs. its Competitors, Q3 2021

Inovalon Holdings Inc reported revenue growth of 19.12 % year on year in Q3 2021, below its competitors' combined revenue growth of 22.81 %.

With a net margin of 5.94 %, Inovalon Holdings Inc achieved higher profitability than its competitors (-19.76 %).

Inovalon Holdings Inc generated 68.95 % of the combined sales of its peer group, down from 69.59 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/INOV/competitors
https://api.csimarket.com/api/v1/companies/INOV/relationships
https://api.csimarket.com/api/v1/companies/INOV/similar
Programmatic access for models, analytics, and integration workflows.

Inovalon Holdings Inc vs. its Competitors, Q3 2021

Revenue growth, year on year

Inovalon Holdings Inc +19.1 %
Competitors combined +22.8 %

Net margin

Inovalon Holdings Inc +5.9 %
Competitors combined -19.8 %

Revenue run-rate vs trailing 12 months

Inovalon Holdings Inc +2.6 %
Competitors combined +2.4 %

TTM net margin

Inovalon Holdings Inc +6.7 %
Competitors combined -28.2 %

TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.

Competitor Financial Benchmarking - TTM Commercial

TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Inovalon Holdings Inc and its 4 competitor groupings. Available under Commercial License.

Entity TTM Revenue Latest Q ×4 Rev Run-rate vs TTM TTM Net Income TTM Net Margin
Inovalon Holdings inc $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Competitors combined $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
High-Confidence Competitors (1) $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Similar Growth & Profitability (7) $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Competitor Financial Benchmarking

TTM revenue, run-rate and net margin benchmarking across Inovalon Holdings Inc's competitor groups requires a Commercial License.

For context: the Cloud Computing & Data Analytics industry grew revenue 1.3% year over year, combined, vs 19.1% for Inovalon Holdings Inc. Inovalon Holdings Inc's share of combined industry revenue moved from 0.12% to 0.14%, a gain of 0.02 percentage points.

Inovalon Holdings Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Inovalon Holdings inc Yes Yes Yes No
Competitors combined (1) 0% 100% 100% 0%
High-Confidence Competitors (1) - - - 100%
Similar Growth & Profitability (8) 100.00 % (8 of 8) 100.00 % (8 of 8) 100.00 % (8 of 8) 37.50 % (3 of 8)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q3 2021

69%market share
  • Inovalon Holdings Inc69.0%
  • Competitors combined31.0%

Share of combined quarterly revenue of Inovalon Holdings Inc and its 1 tracked competitors.

See Inovalon Holdings Inc's full market share breakdown »

INOV Stock Performance relative to its Competitors

INOV Competitors (weighted) Percent change over the selected range

INOV Stock Performance relative to High-Confidence Competitors

INOV High-Confidence Competitors (equal-weighted, 2) Percent change over the selected range

INOV Stock Performance relative to Similar Growth & Profitability Competitors

INOV Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range

Publicly Traded Peers of Inovalon Holdings inc

Revenue and income for trailing 12 months, in millions of $, except employees
Company Market Cap Revenues Income Employees
Inovalon Holdings inc 5,448.61 749.59 50.48 3,000
Tabula Rasa Healthcare inc 266.93 338.12 -95.46 800
SUBTOTAL 5,715.54 1,087.71 -44.98 3,800

Sources: Inovalon Holdings inc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Inovalon Holdings inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.

Inovalon Holdings Inc's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
Msp Recovery Inc Named by the company 85% 2022 to 2026 3
LIFW Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Inovalon Holdings Inc's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.

Inovalon Holdings Inc's Productivity vs Peers Comparison

Revenue and income per employee, trailing 12 months, in $; market cap in millions of $
CompanyMarket CapRevenue / EmployeeIncome / Employee
Inovalon Holdings inc 5,449 249,863 16,826
Tabula Rasa Healthcare inc 267 422,652 -119,320
PEERS TOTAL 267 422,652 -119,320

Inovalon Holdings Inc's Position in Industry Market Structure

Market-capitalization share and concentration across all 148 companies in Inovalon Holdings Inc's industry classification, broader than the peer set above. Market cap in millions of $.

Inovalon Holdings Inc ranks #0 of 148 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 546, indicating a unconcentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).

Rank Company Market Cap Industry Share
1 Automatic Data Processing Inc 105,523 16.92 %
2 Workday Inc 45,532 7.30 %
3 Infosys Limited 43,117 6.91 %
4 Zscaler Inc 31,483 5.05 %
5 Reddit Inc 1,234 5.2%
6 Cognizant Technology Solutions Corporation 1,234 5.2%
7 Verisign Inc 1,234 5.2%
8 Verisk Analytics Inc 1,234 5.2%
9 Toast Inc 1,234 5.2%
10 Wipro Limited 1,234 5.2%
0 Inovalon Holdings inc 5,496 0.00 %
Full Industry Market Structure

Market cap and industry share for the rest of Inovalon Holdings Inc's industry peers requires a Commercial License.

Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-06-03.

Inovalon Holdings Inc's Profitability & Cost Structure

Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Cloud Computing & Data Analytics industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (203 companies).
Metric Company Industry Difference
Gross Margin 73.12 % 51.85 % (avg) +21.3 pp
Operating Margin 12.97 % industry median +19.6 pp
EBITDA Margin 25.56 % 2.97 % (avg) +22.6 pp
Capital Intensity (Capex / Revenue) 5.32 % 5.21 % (avg) +0.1 pp

Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.

Inovalon Holdings Inc's Valuation vs Competitive Position

Valuation multiples vs the Cloud Computing & Data Analytics industry average (203 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns.
Metric Company Industry Average Difference
P/E 118.2x 27.6x +90.6x
EV / EBITDA 35.5x 16.4x +19.1x
P/B 8.2x 4.0x +4.2x
Return on Equity 6.84 % industry aggregate -4.00 %
Return on Invested Capital 3.80 % 1.95 % (avg) 1.85 %

Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.

Inovalon Holdings Inc's Multi-Year Financial Trajectory

Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.
Metric 20162017201820192020
Revenue Growth -2.21 %5.09 %17.43 %21.74 %3.91 %
Operating Margin 8.80 %7.52 %-0.49 %10.82 %10.74 %
Return on Invested Capital 2.14 %2.16 %-0.12 %2.81 %2.88 %
P/E 68.4x61.8x-434.5x137.9x

Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.

Inovalon Holdings Inc's Strategic Group Map

Every company in Inovalon Holdings Inc's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. Inovalon Holdings Inc is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.

Revenue Growth (TTM, %)Operating Margin (%)EVTCAGYSGRVYInovalon Holdings IncDSTRAMPEPAMCACIWDAY

Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.

Inovalon Holdings Inc's Competitive Forces (Porter's Five Forces)

Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.
Force Assessment Basis
Competitive Rivalry High Industry HHI of 546 (see Industry Market Structure & Concentration above)
Barriers to Entry Moderate, in line with the industry Capital intensity (capex / revenue) of 5.32 % vs industry average 5.21 % (see Profitability & Cost Structure above)
Supplier Power Not covered on this page See Inovalon Holdings Inc's dedicated suppliers page for concentration and dependency data
Buyer Power Not covered on this page See Inovalon Holdings Inc's dedicated customers page for concentration and dependency data
Threat of Substitutes - No systematic data source for cross-product substitution exists in this system; not estimated

Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.

Inovalon Holdings Inc's Industry Attractiveness & Competitive Strength

A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.

High Strength
Medium Strength
Low Strength
High Attractiveness
Invest / Grow
Invest / Grow
Selective
Medium Attractiveness
Invest / Grow
Selective
Harvest
Low Attractiveness
Selective Inovalon Holdings Inc
Harvest
Harvest / Divest

Inovalon Holdings Inc falls in the Low attractiveness / High strength cell: Selective.

Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.

Inovalon Holdings Inc's SWOT

Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.

Strengths

  • Operating margin 19.6 points above the industry median.
  • Latest-quarter revenue run-rate is accelerating (+2.6% annualized vs trailing 12 months).

Weaknesses

  • Underperforming the U.S.A. 500 over the trailing 12 months.

Opportunities

No rule matched.

Threats

No rule matched.

Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.

Inovalon Holdings Inc's Financial Strength vs Peers Comparison

Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months
CompanyQuick RatioWorking CapitalDebt / EquityAsset Turnover
Inovalon Holdings inc 0.77 2.19 1.20 0.38
Tabula Rasa Healthcare inc 0.83 1.68 - 0.90

Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.

Inovalon Holdings Inc's Revenue and Income Growth vs Peers

Quarterly revenue and net income growth, year over year and quarter over quarter
CompanyPeriodRevenue Y/YRevenue Q/QIncome Y/YIncome Q/Q
Inovalon Holdings inc Q3 2021+19.1 %+0.9 %+1,326.3 %+22.3 %
Tabula Rasa Healthcare inc Q2 2023+24.0 %+2.0 %--
PEERS TOTAL+20.6 %+1.3 %--

Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.

Inovalon Holdings Inc's Peers' Costs of Sales and Capital Expenditures

Context for revenue growth: peer costs and capex, year over year and quarter over quarter
CompanyPeriodCosts Y/YCosts Q/QCapex Y/YCapex Q/Q
Inovalon Holdings inc Q3 2021+38.9 %+6.4 %+61.4 %-16.7 %
Tabula Rasa Healthcare inc Q2 2023+19.2 %0.0 %-43.5 %+65.2 %

Inovalon Holdings Inc's Returns and Turnover vs Peers

ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover
CompanyROAROIROEReceivables TurnoverInventory Turnover
Inovalon Holdings inc 2.56%2.78%6.84%4.72-
Tabula Rasa Healthcare inc ---17.8036.44

ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).

Inovalon Holdings Inc's Valuation vs Peers

P/E, price to sales, PEG, price to cash flow and price to book
CompanyP/EPrice / SalesPEGP/CFPrice / Book
Inovalon Holdings inc 106.637.270.15-7.10
Tabula Rasa Healthcare inc -0.79-6.74-
PEERS AVERAGE-5.25201.478.29

P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.